Susceptibility of pRb-deficient epidermis to chemical skin carcinogenesis is dependent on the p107 allele dosage

Molecular Carcinogenesis

Volumn 47, Issue 11, 2008, Pages 815-821

  Santos, Mirentxu ^a   Ruiz, Sergio ^a,c   Fernanda Lara, M ^a,d   Segrelles, Carmen ^a   Moral, Marta ^a   Martínez Cruz, Ana Belén ^a   Ballestín, Claudio ^b   Lorz, Corina ^a   García Escudero, Ramón ^a   Paramio, Jesús M ^a  

^a CIEMAT   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Epidermis; p107; Proliferation; Ras; Retinoblastoma; Skin; Tp53; Tumorigenesis

Indexed keywords

PROTEIN P107; RETINOBLASTOMA PROTEIN; CARCINOGEN;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; KERATINOCYTE; MOUSE; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SKIN CARCINOGENESIS; TUMOR VOLUME; ANIMAL; APOPTOSIS; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; EPIDERMIS; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MOUSE MUTANT; PATHOLOGY; SKIN TUMOR;

MUS;

ALLELES; ANIMALS; APOPTOSIS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; EPIDERMIS; GENETIC PREDISPOSITION TO DISEASE; MICE; MICE, KNOCKOUT; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA-LIKE PROTEIN P107; SKIN NEOPLASMS;

EID: 55949125166     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20426     Document Type: Article

References (27)

1. Classon M, Harlow E. The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer 2002;2:910-917.
2. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev 1998;12:2245-2262.
3. Sherr CJ. The INK4a/ARF network in tumour suppression. Nat Rev Mol Cell Biol 2001;2:731-737.
4. Sherr CJ. The Pezcoller lecture: Cancer cell cycles revisited. Cancer Res 2000;60:3689-3695.
5. Weinberg RA. The retinoblastoma gene and gene product. Cancer Surv 1992;12:43-57.
6. Bartek J, Bartkova J, Lukas J. The retinoblastoma protein pathway in cell cycle control and cancer. Exp Cell Res 1997;237:1-6.
7. Sellers WR, KaelinWGJr. Role of the retinoblastoma protein in the pathogenesis of human cancer. J Clin Oncol 1997; 15:3301-3312.
8. Rodriguez-Puebla ML, Robles AI, Conti CJ. ras activity and cyclin D1 expression: An essential mechanism of mouse skin tumor development. Mol Carcinog 1999;24: 1-6.
9. Rodriguez-Puebla ML, de Marval PL, LaCava M, Moons DS, Kiyokawa H, Conti CJ. Cdk4 deficiency inhibits skin tumor development but does not affect normal keratinocyte proliferation. Am J Pathol 2002;161:405-411.
10. Miliani de Marval PL, Macias E, Conti CJ, Rodriguez-Puebla ML. Enhanced malignant tumorigenesis in Cdk4 transgenic mice. Oncogene 2004;23:1863-1873.
11. Paramio JM, Segrelles C, Ruiz S, et al. The ink4a/arf tumor suppressors cooperate with p21cip1/waf in the processes of mouse epidermal differentiation, senescence, and carcinogenesis. J Biol Chem 2001;276:44203-44211.
12. Johnson DG. The paradox of E2 F1: Oncogene and tumor suppressor gene. Mol Carcinog 2000;27:151-157.
13. Ruiz S, Santos M, Segrelles C, et al. Unique and overlapping functions of pRb and p107 in the control of proliferation and differentiation in epidermis. Development 2004;131:2737-2748.
14. Ruiz S, Santos M, Lara MF, Segrelles C, Ballestin C, Paramio JM. Unexpected roles for pRb in mouse skin carcinogenesis. Cancer Res 2005;65:9678-9686.
15. Ruiz S, Santos M, Paramio JM. Is the loss of pRb essential for the mouse skin carcinogenesis? Cell Cycle 2006;5:625-629.
16. Lara MF, Santos M, Ruiz S, et al. p107 acts as a tumor suppressor in pRb-deficient epidermis. Mol Carcinog 2008; 47:105-113.
17. Lara MF, Garcia-Escudero R, Ruiz S, et al. Gene profiling approaches help to define the specific functions of retinoblastoma family in epidermis. Mol Carcinog 2008; DOI: 10.1002/mc.20376
18. Lara MF, Paramio JM. The Rb family connects with the Tp53 family in skin carcinogenesis. Mol Carcinog 2007;46:618-623.
19. Santos M, Perez P, Segrelles C, Ruiz S, Jorcano JL, Paramio JM. Impaired NF-kappa B activation and increased production of tumor necrosis factor alpha in transgenic mice expressing keratin K10 in the basal layer of the epidermis. J Biol Chem 2003;278:13422-13430.
20. Ruiz S, Segrelles C, Santos M, Lara MF, Paramio JM. Functional link between retinoblastoma family of proteins and the Wnt signaling pathway in mouse epidermis. Dev Dyn 2004;230:410-418.
21. Sage J, Miller AL, Perez-Mancera PA, Wysocki JM, Jacks T. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 2003;424:223-228.
22. Macleod KF, Hu Y, Jacks T. Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J 1996;15: 6178-6188.
23. Morgenbesser SD, Williams BO, Jacks T, DePinho RA. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 1994;371:72-74.
24. Pan H, Yin C, Dyson NJ, Harlow E, Yamasaki L, Van Dyke T. Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors. Mol Cell 1998;2:283-292.
25. Balmain A, Kemp CJ, Burns PA, Stoler AB, Fowlis DJ, Akhurst RJ. Functional loss of tumour suppressor genes in multistage chemical carcinogenesis. Princess Takamatsu Symp 1991; 22:97-108.
26. Ruggeri B, Caamano J, Goodrow T, et al. Alterations of the p53 tumor suppressor gene during mouse skin tumor progression. Cancer Res 1991;51:6615-6621.
27. KempCJ, Donehower LA, Bradley A, Balmain A. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell 1993;74:813-822.